Tthose under 30 must be offered an alternative to the AstraZeneca vaccine, it was announced yesterday after the UK drugs regulator discovered the vaccine was linked to blood clots in young people.
The benefits of the AstraZeneca vaccine continue to outweigh the risks for most people, the British drug watchdog said, as European regulators ruled that the unusual blood clots were “very rare side effects” of the drug. vaccine. Scientists also insisted that more research is needed to better understand the risk of these rare blood clots.
This morning, Health Secretary Matt Hancock reiterated that vaccines currently in use in the UK, including the new Moderna vaccine, remain “safe”.
We asked Telegraph readers for their questions about vaccines being rolled out in the UK. Our expert, The Telegraph’s Global Health Security Editor Paul Nuki, will answer these questions at noon today.